“Explore how Inspirational Technologies, PAiNT Network, and PAiNT Research are driving global innovation through hemp’s industrial and medicinal uses, natural therapeutics, and sustainable invention ecosystems. Learn about market trends, regulatory updates, and collaboration opportunities.”
Harnessing Hemp: A Vision for Global Innovation and Natural Therapeutics
Introduction
At Inspirational Technologies, alongside PAiNT Network and PAiNT Research, we champion nature-driven innovation. Hemp—a plant with deep historical roots—is emerging as a cornerstone for sustainable industry and holistic health. Our mission is to explore hemp’s industrial and medicinal potential while advancing natural therapeutics that improve lives globally.
Why Hemp Matters Now
Hemp is no longer just an agricultural commodity—it’s a catalyst for change:
Industrial Applications: Hemp fibers for textiles, bioplastics, and construction materials offer eco-friendly alternatives to petroleum-based products.
Medicinal Uses: Cannabinoids and hemp-derived compounds are being studied for pain management, anxiety relief, and neuroprotective benefits.
Environmental Impact: Hemp cultivation improves soil health, sequesters carbon, and reduces reliance on harmful chemicals.
Industrial Hemp Farm
Global Market Insights
The hemp industry is booming:
Market Size: Projected to grow from $11.03 billion in 2024 to $30.24 billion by 2029, at a CAGR of 22.4%.
Industrial Hemp: Expected to reach $47.82 billion by 2032.
Growth Drivers: Legalization, sustainability focus, and demand for plant-based products.
Regulatory Landscape
Key U.S. updates:
Total THC Standard: Effective November 2026, hemp will be defined by total THC content.
THC Caps: Finished products must contain ≤0.4 mg total THC per package.
Synthetic Cannabinoids: Excluded from legal status.
For innovators, this means focusing on industrial hemp applications and compliant medicinal uses.
Same Leaf Style – Marijuana adds a THC molecule.
Our Research Focus
At PAiNT Research, we are committed to:
Innovative Extraction Methods
Therapeutic Formulations
Industrial Scale Solutions
Natural Therapeutics: Beyond Hemp
Our vision extends to:
Plant-based remedies for chronic conditions.
Functional botanicals for mental health.
Synergistic formulations combining hemp with other natural compounds.
Global Implications and Collaboration
Hemp innovation can:
Drive Economic Development
Advance Climate Action
Improve Healthcare Access
Connecting with the Lemelson Foundation
The Lemelson Foundation fosters invention ecosystems through:
Invention Education
Entrepreneurship Support
Climate Action Initiatives
Our hemp and natural therapeutics research align with Lemelson’s focus on impact invention—solutions that are socially beneficial, environmentally responsible, and financially sustainable.
A Call to Collaborate
As Steven Smith, CEO and founder of Inspirational Technologies, I believe collaboration is the key to unlocking hemp’s full potential. Whether you are a researcher, entrepreneur, or policymaker, we invite you to join us in shaping a future where nature and technology converge for the greater good.
Next Steps
Connect with us at Inspirational Technologies for joint research opportunities.
Explore PAiNT Network for knowledge-sharing and innovation forums.
Partner with PAiNT Research to advance hemp-based solutions globally.
Predictive Artificial Intelligence News & Technology1st Hemp USA News is a resource of Inspirational Technologies (2021)Logo by Steven M Smith Created 3/1/2014
Co-edited by Steven Smith, PAiNT Research Hemp Is Now A Viable Agriculture Phenomenon Cannabis and the Endocannabinoid System; The Wonders of CBDs CBD Molecule The following is a reprint with updated references. Cannabinoids are the chemical compounds made by the cannabis plant that unlock its many healing secrets. There are over 100 known cannabinoids and these chemicals imitate the endocannabinoids naturally produced in the human body. The shiny little crystals you see on cannabis buds are called trichomes where cannabinoids are stored. Human bodies (and many animals) have endocannabinoid systems (ECS), meaning that cannabinoids are naturally made so they can bind to endocannabinoid receptors creating changes in our physiology. To understand the master gland and immune system of the human body it is crucial to have a basic understanding of the endogenous cannabinoid system, otherwise known as the endocannabinoid system (ECS). The endocannabinoid system is essential to human health because it maintains homeostasis in the body. Research into the endocannabinoid system has increased in recent years as scientists begin to reveal how complex and important this system is to our bodies. The legal cannabis movement started in San Francisco in the early 1990’s when it was discovered that cannabis treated many symptoms that AIDS patients suffered from, including pain. It was medical marijuana laws that changed the legal status of cannabis nationwide, opening the doors for research and an adult-use market and creating a path towards full legalization. Cannabis patients across the country have used the plant to treat a growing number of medical conditions. In Colorado alone, there are nine different qualifying conditions for a medical card: cancer, glaucoma, HIV or AIDS, cachexia (wasting syndrome), persistent muscle spasms, seizures, severe nausea, severe pain, and Post Traumatic Stress Disorder (PTSD).
What Do CBD’s Do? The endocannabinoid system (ECS) is responsible for maintaining homeostasis in the body. Homeostasis is defined as: “any self-regulating process by which biological systems tend to maintain stability while adjusting to conditions that are optimal for survival.” If homeostasis is successful, life continues; if unsuccessful, disaster and ill health ensues. The endocannabinoid system is made up of three parts: cannabinoid receptors, endocannabinoids, and metabolic enzymes. • Endocannabinoid receptors are found throughout the body on the surface of cells in the brain, organs, tissues, and glands. These receptors are embedded in cell membranes and produce varying reactions when stimulated by cannabinoids. • Cannabinoids come from two distinct places — the body, which produces naturally occurring endocannabinoids, and foods like the cannabis plant, which produces phytocannabinoids. • Metabolic enzymes act like a natural referee in that they destroy endocannabinoids once they are used up by the body. The two main metabolic enzymes are fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL). This self-regulating system ensures the interaction of CBDs with the ECS only happens when needed and therefore keeps the workings of the endocannabinoid system relatively quiet to the conscious brain. Because homeostasis is so important to health, all vertebrates and invertebrates are known to have an endocannabinoid system.
Cannabinoids can also be produced synthetically. Marinol (dronabinol) and Cesamet (nabilone) are synthetic versions of THC that have FDA approval to be marketed and sold as a prescription drug. Synthetic cannabinoids do unlock the endocannabinoid system to produce effects, but they often fail to incorporate the entourage effect which states that the sum of the different cannabinoids works better as a whole unit than any cannabinoid individually. With an understanding of the endocannabinoid system and its role in ensuring homeostasis in the body, it may be easier to see how this could be true. The Endocannabinoid System Despite its critical importance, the endocannabinoid system (ECS) was only discovered in the early 1990s when Lisa Matsuda, a researcher at the National Institute of Mental Health, and her colleagues discovered a DNA sequence that defines a THC-sensitive receptor in a rat’s brain. This discovery was quickly followed up with further evidence by Dr. Raphael Mechoulam, the famous chemist who discovered THC. With less than 30 years of research, the endocannabinoid system is one of the least studied systems in the body. Currently, restrictions on cannabis research limit what scientists can examine in terms of furthering the understanding of how cannabis and hemp interact with the endocannabinoid system. Two cannabinoid receptors have been discovered by researchers: CB1 and CB2.
CB1 is found in the central and peripheral nervous system. It’s also found in the brain and is the receptor that THC interacts with, giving the user a “high.” CB2 receptors are predominantly found in the immune system and the gastrointestinal system where they regulate inflammatory responses in the bowels. CB2 receptors are also found in the brain, although not as densely as CB1 receptors. These receptors, a large part of the endocannabinoid system, play roles in regulating cardiovascular activity, appetite, mood, memory, and pain in the body. CBD does not fit exactly into either CB1 or CB2 receptors. CBD stimulates both receptors and causes a reaction without binding directly, creating changes in cells that contain them. CBD also binds to a protein-receptor couple, TRPV-1, responsible for regulating body temperature, pain, and inflammation. CBD is also known for counteracting the effects of THC, activating serotonin receptors, and inhibiting a gene attributed to several cancers. CBD has grown in popularity recently as research and anecdotal evidence increasingly demonstrates the impact it can have on the body. The body’s endocannabinoid system reacts to CB1 and CB2 based upon the organ or bodily system that is sensitive to one or both. The brain is especially sensitive to CB1, the lungs to CB1, the spleen to CB2, the vascular system CB1, the pancreas to CB1 & CB2, the liver to CB1 & CB2, reproductive organs to CB1, the colon to CB2, the muscles to CB1, the immune system to CB2, and the bones to CB2. The endocannabinoid system (ECS) is also involved in regulating a variety of physiological and cognitive processes including fertility, pregnancy (during pre- and postnatal development) appetite, pain-sensation, mood, and memory, and in mediating the pharmacological effects of cannabis. The ECS is also involved in mediating some of the physiological and cognitive effects of voluntary physical exercise in humans and other animals, such as contributing to exercise-induced euphoria as well as modulating locomotor activity and motivational salience for rewards. In humans, the plasma concentration of certain endocannabinoids (i.e., anandamide) have been found to rise during physical activity; since endocannabinoids can effectively penetrate the blood–brain barrier, it has been suggested that anandamide, along with other euphoriant neurochemicals, contributes to the development of exercise-induced euphoria in humans, a state colloquially referred to as a runner’s high. Cannabinoids Cannabinoids are broadly known for their anti-seizure, anti-inflammatory, anti-nausea, anti-fungal, and anti-cancer effects — and science has just scratched the surface. How much these effects are expressed is a result of the entourage effect is not fully known. The entourage effect states that the cannabinoids work better in tandem than they do alone. THC and CBD produce stronger healing properties together that are shown differently based on their concentrations and the presence of other cannabinoids. In addition, terpenes, the oils that give cannabis its fragrance, contribute to the therapeutic effects of the plant on the body when paired with cannabinoids. The powerful combination of these naturally occurring chemicals produces the medical effects that have given cannabis its reputation as a wondrous medical agent.
In California, there are twelve qualifying conditions for a medical cannabis card, including one described as, “any other chronic or persistent medical symptom that substantially limits the ability of the person to conduct one or more major life activities (as defined by the Americans with Disabilities Act of 1990) or, if not alleviated, may cause serious harm to the patient’s safety or physical or mental health.” There are over 100 known cannabinoids and we’ve only briefly described a few. There is a lot more research to be done to understand the intricacies of each cannabinoid and how they interact with each other. Cannabinoids can bind to receptor sites in either the brain (CB-1) or the body (CB-2). Cannabinoids will produce different effects on the body depending on which type of receptor site they bind to. Cannabis strains are filled with multiple cannabinoids that when consumed, bind to these sites, creating a symphony of effects on the body and thus corresponding to the wide variety of healing properties. This is why one plant can treat many different conditions. Cannabinoids begin as cannabinoid acids that are activated when heated. This heat-based activation, also known as decarboxylation, removes the acid from the molecule, turning it into a bioavailable compound that the body can register. The decarboxylated molecule is often more powerful and produces a different effect on the body than the acidic version. This is why you see both “THCA” and “THC” when looking at the contents of a cannabis strain.
🌿 Introduction: A Living System of Discovery The endocannabinoid system (ECS) remains one of the most fascinating regulatory networks in human biology. From mood and sleep to immune balance and pain modulation, the ECS is a master regulator. Cannabinoids like CBD interact with this system in ways that continue to inspire both scientific inquiry and public imagination. With the PAiNT Research Optics Palette – Green, we bring a sharper lens to this evolving field—highlighting not only the breakthroughs but also the blind spots that demand further exploration.
🔬 Current Research Strides
Clinical Expansion: CBD has moved from anecdotal wellness use into formal clinical trials for epilepsy, anxiety, inflammation, and neurodegenerative conditions.
Mechanistic Insights: Researchers are mapping receptor subtypes (CB1, CB2, and beyond), uncovering how cannabinoids influence neurotransmitter release, immune signaling, and vascular health.
Formulation Innovation: Advances in delivery systems—nanoemulsions, transdermal patches, and targeted oral formulations—are improving bioavailability and consistency.
Agricultural Progress: Hemp cultivation under the 2018 Farm Bill has expanded genetic diversity, enabling strains optimized for high-CBD, low-THC production.
⚖️ Current Limitations
Regulatory Barriers: Federal scheduling and fragmented state laws continue to slow large-scale, multi-site clinical trials.
Data Gaps: Long-term safety data, especially for chronic use and polypharmacy interactions, remain incomplete.
Standardization Issues: Variability in plant genetics, extraction methods, and labeling practices undermines reproducibility and consumer trust.
Equity in Access: Research and product development often overlook marginalized communities most affected by health disparities and cannabis criminalization.
🎨 The PAiNT Optics Palette – Green
This editorial lens emphasizes sustainability, wellness, and regenerative potential. “Green” is not only the color of the plant but also a metaphor for growth, balance, and ecological responsibility. Through this palette, PAiNT Research frames CBD and ECS science as part of a broader movement toward integrative health and environmental stewardship.
🚀 Preparing for PAiNT Your Wagon
This blog is the first in a living research series. The next installment, PAiNT Your Wagon, will expand the conversation—exploring how predictive AI, narrative storytelling, and community engagement can accelerate cannabinoid research and policy reform. Together, these pieces will form a living research blog, where each chapter builds on the last, offering readers not just information but a roadmap for advocacy, innovation, and wellness.
✅ Closing Note The ECS is not just a scientific curiosity—it is a bridge between biology, wellness, and culture. By applying the PAiNT Research Optics Palette – Green, we illuminate both the promise and the challenges of CBD research, preparing the ground for deeper inquiry and collective action.
I hope this information was helpful and informative. If you have any more questions, please feel free to ask me. 😊 Inspirational Technologies – IT is Time
We, at Inspirational Technologies are at the forefront of Inspirational and Frontrunners on the frontier of current technology.
We are often faced with our own personal conflicts which directly influence our interactions with our peers and family.
When Inspirational Technologies is an endorsement of the “Cannabis” approach to the medical condition, we say, let’s let the look at the data and the people who say that they benefit for cannabis alternatives.
Our mission is to shape public perception and policy through credible, engaging narratives that empower communities. With the PaiNT Network, we are extending that mission into the realm of predictive intelligence. By blending editorial rigor with AI foresight, we are creating a platform that doesn’t just inform—it inspires action.
As Steven Smith notes:
Looking Ahead The launch of PaiNT Research is only the beginning. In the coming months, Inspirational Technologies will:
• Roll out “Engage → Palette” cycles on our blog, showing how dialogue evolves into curated insights. • Publish “PaiNT Your Wagon” action briefs to guide policymakers and advocates. • Release “PaiNT You a Picture” visuals to make complex science accessible. • Amplify insights through “PaiNT the Town”, ensuring that predictive intelligence reaches the audiences who need it most.
P a i N T Pallette 2025P a i N T Your Wagon 2025P a i N T You a Picture 2025P a i N T the Town 2025
We, at Inspirational Technologies are at the forefront of Inspirational and Front runners on the frontier of current technology. ___________________________________________________________________________________________________All Rights Reserved – Inspirational Technologies 2025 We hope this information has been helpful and informative. Don’t hesitate to reach out with any further questions. 😊
Predictive Artificial Intelligence News & Technology1st Hemp USA News is a resource of Inspirational Technologies (2021)Logo by Steven M Smith Created 3/1/2014
Inspirational Technologies presents the Hemp Story “MISUNDERSTOOD” – Read it and REAP then Weep (2025)
Be determined to help us make the planet a better place by supporting our mission to inform and educate the public about the many benefits ‘hemp’ once brought to our daily lives. Take the time to learn how hemp can contribute to positive changes in our future. We hope you’ll be inspired by hemp and the shared future we can create together. Thank you for your support. Steven M. Smith, Inspirational Technologies, dedicated to your health, wellness, and beauty since 2014. The following Hemp Story is rewritten from its’ original post in 2019.
A forbidden fiber in the U.S. since 1970, hemp has taken the heat for almost five decades. Until the Farm Bill passed in December of 2018, hemp was federally illegal to grow for commercial purposes, making it risky for businesses to invest in a new crop that was incorrectly classified as a drug. Imagine a sweater softer than any fabric you’ve ever felt before, and more durable than cotton. Imagine a car built with something lighter than steel that could stand 10 times the impact without denting. 
Imagine if you could save four acres of trees by making paper with 1 acre of hemp. Imagine biodegradable Legos.
Now imagine all this possibility actually exists but you can’t enjoy any of it because people in power once decided the plant from which it’s all derived has a scorned cousin named “marijuana.” If you can wrap your mind around this dereliction of logic, only then can you begin to understand the painfully silly policies America’s had in place that have kept hemp from coating our farmland with hues of pale yellow and light green. That longstanding logic has been costly for our country. United States’ hemp prohibition has suppressed potential jobs for farmers, products for consumers, and medicine for patients.
Cousin or not, the reality is, hemp can’t get you high just as near beer can’t get you drunk. Despite all that–and while near beer takes up three spots in every Walmart in America– hemp has been largely banned in the United States, until now. To understand the differences between hemp and marijuana it’s critical to know what each distinctly different plant is capable of doing. The Ministry of Hemp offers the most comprehensive and easily digestible explanation of hemp versus marijuana. The 2018 Farm Bill: How we got here. Here’s what happened. Way back when, an angry and lobby-influenced Congress passed the Marihuana Tax Act of 1937, which effectively outlawed the possession of cannabis—including hemp—after hundreds of years of growth and use from the time of British colonization onward. While that law was repealed in the late 1960s, cannabis was quickly included as a Schedule 1 drug (the most “dangerous” class of drugs including heroin) in the Controlled Substances Act, a designation which continues to this day.
After 81 years, the 2018 Farm Bill represents the largest step towards undoing the racist and scientifically baseless legacy of the Marihuana Tax Act of 1937.
The 2018 Farm Bill officially reclassifies hemp for commercial uses after decades of statutes and legal enforcement conflating hemp and marijuana, the Farm Bill distinguishes between the two by removing hemp from the Controlled Substances Act. (While the two are closely related, hemp lacks the high concentration of THC that is responsible for the high from smoking marijuana.) This would effectively move regulation and enforcement of the crop from the purview of the Drug Enforcement Agency to the U.S. Department of Agriculture.
The 2018 Farm Bill expands upon provisions in the 2014 version of the annual bill, which created Hemp Pilot Programs. These Hemp Pilot Programs “created a framework for the legal cultivation by states of ‘industrial hemp’ without a permit from the Drug Enforcement Administration.” The 2014 Hemp Pilot Programs were a success for farmers and consumers across the U.S., from Colorado to North Carolina. Senate Majority Leader Mitch McConnell continues to be ardently anti-marijuana, despite the success of these programs and the fact that 62% of Americans say recreational marijuana should be legal. Nevertheless, McConnell and Senate Republicans read the political tea leaves and will now recognize the important differences between marijuana and hemp. In doing so, they’re creating an exciting time for entrepreneurs, CBD advocates, and farmers across the country. US previous administration trade wars were hurting farmers to the tune of billions of dollars. Wheat, soybean, and corn farmers have been targeted by China as the potent measure in its escalating tariff battle with the U.S. In 2017, China imported more than $24 billion in agriculture products from the U.S. The world’s top wheat consumer, China and purchased 1.6 million tons of U.S. wheat worth $391 million. At the same time, China bought $14 billion in soybeans for personal and animal consumption from the U.S. last year–more than any other agricultural commodity, and the country’s corn imports from the U.S. were worth $160 million.
All that’s changed with the high trade tariffs Trump’s levied on countries who import our products. Analysts and existing evidence suggest the soybean trade conflicts will be in favor of fellow exporters, Brazil and Argentina, rather than the U.S. The tariff could drop China’s imports of soybeans by 69% on average. The estimated effect of China’s 25% tariff on U.S. soybean imports would cut income for a midsize Illinois grain farm by an average of 87% over four years, prompting a loss of more than $500,000 in the farm’s net worth by 2021. It’s a messy situation. Trump needed a win, and farmers did too. Distinguishing between commercial hemp and marijuana, legalizing the former, is that much-needed reprieve. “We’re so pleased farmers across America now have the freedom to consider integrating this important crop into their production, particularly with the trade concerns around other crops such as soybeans, corn, and wheat,” said Elizabeth Hogan, VP of Brands at GCH Inc., the company behind Willie Nelson’s cannabis brands. Hemp legalization will transform it from niche interest and return it to cash crop status.
Using Hemp as Rotational Crop
Hemp is a farmer’s friend because compared with cotton, corn, and soybeans, it requires little water, isn’t picky when it comes to poor soil. It grows tightly spaced, thus crowding out weeds, and boasts a deep, soil-aerating root system. Despite all its advantages, and because growing it is illegal with the exception of limited licenses, the U.S. imports approximately $60 million worth of hemp from overseas countries like China. Political leverage This Farm Bill gave Trump Administration a powerful tool in their bargaining with China. As I wrote earlier this year in Forbes, China produces 50% of the world’s cannabis supply, with a large majority of that supply being the THC-lacking hemp variety; this gives China “massive economic potential” which “poses a threat to cannabis interests around the world and particularly in the U.S. market.”
Studies at Bejing’s Hemp Research Center revealed the variety of plant uses, prompting China to expand its hemp production which is a mere fraction of its world-leading cotton production. China not only has the product, but they have the cultivation techniques and commercial technologies to capitalize on that supply. And they are ramping up to leverage their competitive hemp advantage, expecting an eager demand from U.S. manufacturers given hemp’s rise in popular applications. By contrast, U.S. farmers grew merely 25,000 acres of hemp in the entire country in 2017. To give that context, that’s the same amount of land Bill Gates bought in Arizona to create a small, futuristic city.
That’s cool for a retirement project if you’re a billionaire, but hardly enough land to launch any sort of industry. And of that, about 70% of which was used to make CBD oil. Only recently have we seen an increase in manufacturers using hemp fibers to make fabrics, construction materials, health products, and other consumer goods.
With the passage of the 2018 Farm Bill, America will have a chance to counter China’s massive influence in the cannabis hemp industry. But it will mean playing catch-up for the foreseeable future. Currently, hemp cultivation techniques in America lag far behind other crops—it still has to be harvested by hand even. Even though marijuana is legal in China, the country has funded research into the plant and its cultivation, placing it miles ahead of other countries. The Farm Bill will help hemp farmers and entrepreneurs. 
The 2018 Farm Bill will radically overhaul America’s relation to hemp and could unleash a hemp renaissance in the coming years that will close the gap between the U.S. and China. As a Schedule 1 substance alongside marijuana, hemp farmers and entrepreneurs in the U.S. have faced many barriers to doing business. Interstate commerce for hemp products was almost non-existent and financing was difficult to come by. But all that is set to change.
According to the American Agriculturist, the 2018 Farm Bill will allow hemp to be regulated by the USDA, including the labeling of American-grown hemp as certified organic; interstate hemp commerce will be legalized; financing and research opportunities will open up; hemp farmers will be guaranteed water rights; the definition of hemp will be altered to make it a non-drug commodity.
Hemp has hundreds of uses, many of which are yet to be discovered or fully realized thanks to the lack of available research funds. From textiles and plastics to livestock feed and home cooking, hemp has many applications that can reduce our dependence both on other countries and fossil fuels. Driven by explosive growth in hemp-based consumer products, the global hemp market is expected to jump to $10.6 billion by 2025. 
Everything from our vodka to our cars is waiting to be reimagined in the future with legal hemp. Many people won’t even realize how much their lives are affected by cannabis-based products. One of the most exciting applications of hemp lies in the extracted cannabinoids or CBD oil. According to the Washington Post, “dozens of studies have found evidence that the compound can treat epilepsy as well as a range of other illnesses, including anxiety, schizophrenia, heart disease, and cancer.” With the legalization of hemp, CBD can be regulated and researched much more than before to truly understand the medical efficacy for a wide range of diseases.
“We continue to see great progress towards a new perspective on cannabis within the US. Within healthcare, several conditions and certain patient profiles rely heavily on CBD-only products of which the proposed Farm Bill will work to dramatically improve access to patients – not only in the US but globally,” said Prad Sekar, CEO of CB2 Insights in a written interview. All of those uses make hemp a profitable cash crop for suffering farmers, with some early commercial growers reporting $100 per-acre more profit on hemp than canola. Hemp grown for CBD oil, on the other hand, can take in $8,000 per acre versus $600 per acre for corn. In particular, hemp can be a boon for arid western states. According to Pacific Standard,
Hemp is thus profitable and sustainable, two words which have eluded many U.S. farmers as of late. Hemp cultivation could provide much-needed relief as farmers struggle to find markets for millions of bushels of crops during the trade wars. Now, instead of importing an estimated $100 million of hemp products every year, that money will go to American farmers and entrepreneurs.
Bruce Perlowin, CEO of Hemp, Inc, believes hemp legalization will drive disenfranchised farmers “back-to-the-land” now that they’ll have a solid economic basis in industrial hemp to rely on. “Our strategy has been to partner with farmers across the country in states where hemp cultivation and manufacturing is legal to provide them with the infrastructure needed to make a profit off this incredible crop, and this bill will be an incredible boon for the American small family farm,” Perlowin continued “The health and wellness industries are in for a major overhaul with the massive research and development and exploration into CBD‘s, CBGs, CBN’s and 113 other cannabinoids as well as some 300 terpenes found in the industrial hemp plant.”
AllRightsReserved-InspirationalTechnologies2024
What developments have occurred since the signing of the 2018 Farm Bill,
especially regarding how individual states are addressing issues related to CBD and Kratom?
Since the 2018 Farm Bill, states have rapidly evolved their regulations on CBD—especially hemp-derived intoxicants—
and are beginning to address Kratom with increasing scrutiny and legislative action.
🧪 CBD: From Wellness to Regulatory Whiplash Federal Shift (2018–2025): • The 2018 Farm Bill legalized hemp (≤0.3% delta-9 THC), opening the door for CBD products nationwide. • However, it inadvertently created a loophole for intoxicating hemp derivatives like delta-8 THC, delta-10, and THCa, which are chemically altered but still derived from legal hemp. • The FDA has not approved CBD as a dietary supplement or food additive, leaving states to fill the regulatory vacuum. State-Level Responses: • Early years (2018–2022): Most states treated hemp-CBD as a wellness product, with minimal oversight. • By 2023: Only 8 states had rules addressing intoxicating hemp derivatives. • By mid-2025: Over 40 states now regulate or ban hemp-derived intoxicants. These laws include: • Potency limits and age restrictions • Licensing and testing requirements • Labeling rules (QR codes, batch IDs, warnings) • Bans on chemical conversion processes used to create synthetic cannabinoids Examples: • California allows CBD in foods/beverages but restricts intoxicating hemp. • New York enforces age limits, serving caps, and QR-linked COAs. • Texas permits food/supplement formats with strict labeling; smokable hemp is restricted. • Indiana pioneered QR-code traceability and batch testing.
🌿 Kratom: A Rising Focus While Kratom wasn’t addressed in the 2018 Farm Bill, its growing popularity has prompted state-level action: • Some states (e.g., Alabama, Arkansas, Indiana) have banned Kratom outright due to concerns over addiction and safety. • Others (e.g., Florida, Georgia, Utah) have passed Kratom Consumer Protection Acts, which regulate: • Minimum age for purchase • Labeling and purity standards • Prohibitions on adulterated or synthetic Kratom This patchwork reflects rising public health concerns and a push for consumer safety without federal oversight.
We, at Inspirational Technologies are at the forefront of Inspirational and Frontrunners on the frontier of current technology.
We are often faced with our own personal conflicts which directly influence our interactions with our peers and family.
___________________________________________________________________________________________________All Rights Reserved – Inspirational Technologies 2025We hope this information has been helpful and informative. Don’t hesitate to reach out with any further questions. 😊Inspirational Technologies Inspirational Technologies (2014) Background Noise Studios Logos by Steven M Smith
Inspirational Technologies (2024) All Rights Reserved
*This site operates with minimal compensation for product sales. Humanitarian values are prioritized over monetary gains. Income supports research, development, discovery, and healing.
Inspirational Technologies is committed to your health, wellness, beauty, and enrichment. Reporting on today’s botanical and skincare product benefits.
A Decade of Hemp Innovation: Inspirational Technologies’ Journey and Next Chapter
This is my past, present, and future vision by Steven M. Smith, Founder & CEO of Inspirational Technologies – September 2025 – Over a decade ago, Inspirational Technologies set out to combine natural wellness with advanced science, and now we’re taking a bold leap forward. Founded in 2013 by Steven Smith, our journey began as a small Florida startup with a mission to connect traditional botanical remedies with modern technology. From those modest beginnings, we’ve evolved into a leader in hemp-based innovation, driven by resilience, discovery, and a strong sense of purpose. Today, we’re thrilled to unveil a new chapter for Inspirational Technologies—building on our foundation and embracing the future of hemp and cannabinoids to bring relief to even more people.
2013–2015: Laying the Groundwork
Logo by Steven M Smith Created 3/1/2014
In the early years (2013–2015), we laid critical groundwork. Steven Smith’s background in plant sciences and passion for holistic health drove the initial focus on researching plant-based compounds, particularly those in hemp and other medicinal herbs. We were essentially a research lab with a big dream: to validate traditional botanical remedies using rigorous modern science. During this time, we established an education hub on our website (InspirationalTech.org) to share research updates and demystify hemp for the public. This proved vital in combating public misconceptions, as many people at the time still conflated hemp with psychoactive cannabis. Indeed, throughout the 20th century, stigma and prohibition had severely complicated cannabis research, and in the early 2010s hemp was legally categorized alongside narcotics despite its lack of THC. Navigating this environment was challenging – regulations were murky, funding was limited, and we often had to explain that hemp isn’t about “getting high,” but about healing. [Frontiers…: from …][What Does…usinesses?]
Industial Hemp Field
Challenges: Regulatory uncertainty was the toughest hurdle in our infancy. Government rules around cannabis research were ambiguous or restrictive, making it difficult to source materials and secure funding. Public perception was another obstacle; early on, some investors and consumers were wary, not yet educated on the difference between non-intoxicating hemp compounds and marijuana. We tackled these challenges through education and transparency. By openly sharing scientific findings and safety data on our website and in community seminars, we started changing minds.
In 2014, our persistence paid off: we secured our first private investment, providing much-needed R&D capital, and validated our vision to those who believed in the potential of cannabinoids. That same year we launched our website as a content hub, positioning Inspirational Technologies as a trustworthy voice explaining the science of CBD and hemp. This focus on education built credibility and began eroding the stigma.
Successes: Despite the headwinds, by 2015 we had established a solid foundation. We had a small lab, a growing network of academic collaborators, and early data hinting at hemp’s therapeutic promise. For example, our team initiated studies on hemp-derived compounds and their effects on conditions like inflammation and anxiety, drawing on expertise from university partners. These academic collaborations not only guided our research but also validated our early findings in peer-reviewed settings, showing that our work was on the right track. We closed 2015 with optimism – and a budding reputation as pioneers willing to push botanical science into new territory.
2016–2018: Expanding into Hemp and Cannabinoids
By the mid-2010s, cannabidiol (CBD) was gaining mainstream attention as a potential wellness game-changer. Research interest in CBD was exploding worldwide, and public awareness of hemp’s benefits was on the rise. Inspirational Technologies embraced this momentum and shifted focus squarely onto hemp-derived cannabinoids. This period marked our evolution from a general plant research startup into a dedicated hemp innovation company.
Research Milestones: Between 2016 and 2018, we embarked on ambitious studies of CBD’s potential health benefits. Our research teams (now working with medical scientists) explored how CBD could help reduce anxiety, alleviate inflammation, and even act as a neuroprotective agent for the brain. Early results were promising: for instance, preliminary experiments suggested CBD had notable anti-inflammatory effects (supporting what many others were finding), and could modulate stress responses in animal models. We weren’t alone in these discoveries – around this time scientific literature was burgeoning with cannabinoid research. Academic partners working with us published validating findings, adding credibility. The scientific community was confirming what we believed: CBD and related cannabinoids held real therapeutic promise. Notably, evidence began emerging that CBD might provide relief in anxiety without the downsides of THC. (In fact, a few years later a clinical trial would show CBD can quell anxiety symptoms effectively without impairment.) The more data we gathered, the more confident we became that our path was the right one. [CBD shown…e with THC], [CBD shown…e with THC]
Product Development: Research findings quickly fed into product ideas. By 2017, we had developed our first prototypes of CBD-infused wellness products, including a topical cream for pain relief and a tincture (oral drops) for stress and general wellness. Formulating these was an exciting step from lab bench to real-world application. We sourced high-quality hemp extracts and combined them with synergistic herbs, leveraging our roots in botanical science to create unique blends. Each prototype was tested for safety and efficacy in small trials. The feedback from early testers was encouraging – users reported less joint pain after applying the cream, and better sleep with the tincture. This R&D phase taught us about effective dosing, bioavailability (for example, how well the body absorbs CBD in different forms), and user preferences. It set the stage for the full product line we’d launch once the regulatory coast was clear.
Obstacles: If you rewind to 2017, selling a hemp-based product was not straightforward. Federal law still treated hemp extracts in a gray zone, which made distribution and marketing a tricky affair. We could develop products and even give out samples, but large-scale sales were hampered by legal ambiguity. Shipping CBD across state lines lived in a legal limbo – technically hemp was still a Schedule I substance federally, even though it has no high-inducing THC. This meant we had to proceed carefully and focus on states with clear hemp programs. We also had to be very cautious about marketing language, avoiding any medical claims that could draw ire from regulators (the FDA had started warning companies about unproven claims). Yet, we persisted, keeping our operations lean and compliant. We engaged with industry groups advocating for hemp law reform, and continuously educated lawmakers and the public on CBD’s safety. All of this groundwork positioned Inspirational Technologies to spring ahead when the law finally caught up with science. [What Does…usinesses?], [What Does…usinesses?]
A Turning Point – Legalization: Late 2018 brought the breakthrough we and the entire industry had been waiting for. The U.S. Congress passed, and the President signed, the Agriculture Improvement Act of 2018 the “Farm Bill” (see our story)
December 2018 – The Farm Bill Legalized Hemp
2019–2022: Growth through innovation and Partnerships
With legal clarity achieved, Inspirational Technologies moved full speed from R&D into the marketplace. The period from 2019 to 2022 was one of rapid growth, new partnerships, and establishing our leadership in the hemp wellness space. We transitioned from a small startup into a recognized brand with a national reach.
Commercial Launch: In early 2019, we officially launched our first line of CBD-based wellness products to the public. The line included the refined versions of our topical CBD cream and sublingual tincture, now branded under the Inspirational Technologies banner, as well as capsules and an all-natural CBD balm. We leveraged e-commerce and select health store partnerships for distribution. The timing was perfect: consumer interest in CBD had exploded, and people were eager to try these newly legal remedies. In fact, by 2020 nearly one-third of U.S. adults had used a CBD product, a huge leap in adoption from just 14% in 2019. We were ready to meet the demand with products formulated on a foundation of science and quality. Each batch was lab-tested for purity and potency, and we published the results online to continue building trust through transparency.
1st Hemp USA 2021 Inspirational Technologies
Partnership with hempSMART:
A key milestone in this phase was our strategic partnership with hempSMART in 2019.
HempSMART – a California-based company known for its science-driven CBD formulations – shared a similar ethos with us. By partnering, we aimed to combine our strengths: Inspirational Technologies’ research and product innovation, with hempSMART’s established marketing channels and customer base. Together, we celebrated on product development and education. For example, we co-hosted webinars featuring experts like Paula Vetter (hempSMART’s medical advisor) to inform consumers about CBD’s benefits. This partnership expanded our reach across the U.S. and even into international markets where hempSMART had a presence. It was a win-win: hempSMART gained new formulations and R&D support, while we gained a ready distribution network and a boost in brand visibility. Collaboration has always been in our DNA, and this was a powerful example of how working with like-minded innovators could amplify our impact.
Scaling Up: Internally, these years saw our team grow and our capabilities scale. We onboarded new talent – from formulation chemists to regulatory consultants – to handle everything from product manufacturing to compliance in a fast-evolving regulatory environment. In 2020, hempSMART opened a larger production facility in Florida, enabling us to increase output to meet surging demand.
Our efforts at maintaining high standards earned recognition: by 2021, Inspirational Technologies was being recognized as a leader in hemp-based innovation, with industry magazines featuring our story and calling out our commitment to quality. We also invested in intellectual property, filing patents related to advanced cannabinoid extraction techniques and delivery methods (like a water-soluble CBD nanoemulsion to improve absorption).
This era wasn’t without its challenges, of course. The regulatory landscape, while improved, remained complex – the FDA still hadn’t fully figured out how to categorize CBD products, and we had to stay on top of patchwork state regulations. Public perception, however, continued trending in our favor. By 2022, 60% of Americans had tried CBD and believed in its benefits, reflecting a massive shift in acceptance. What was once fringe had become mainstream, found in everything from gummies and lattes to pain salves. We made sure Inspirational Technologies stood out in this crowded market by doubling down on science and trust – emphasizing evidence-backed uses, avoiding hype, and advocating for sensible regulations to protect consumers. Our reputation for integrity became one of our strongest selling points. [CBD Statis…bes Health]
Highlights 2019–2022: We achieved several key milestones in this growth phase: new product launches (including a popular CBD + herbal adaptogen capsule in 2021), revenue growth that outpaced our projections, and an expanding loyal customer community. We also saw the broader hemp industry flourish, validating our faith in this plant. (U.S. CBD product sales skyrocketed from about $108 million in 2014 to nearly $1.9 billion by 2022, illustrating the boom we were part of.) Inspirational Technologies had firmly established itself — not just as a company selling wellness products, but as an innovator helping to shape an entire industry. [CBD Statis…bes Health]
2023 and Beyond: Embracing a New Frontier
The stage is set for an exciting new chapter. As the metrics above show, the environment in 2023–2025 is remarkably different from a decade ago. Consumer acceptance of hemp remedies is at an all-time high, and the market has grown exponentially. With widespread legality and a mountain of supporting research, cannabinoids are poised to transform mainstream healthcare and wellness. In this context, Inspirational Technologies is embracing a new frontier. Our new direction will leverage everything we’ve learned over the past 12 years and push further to realize the full potential of hemp-based science. Here’s what to expect as we move forward:
1. Pioneering Advanced Therapeutics: The heart of our new direction is a commitment to deeper scientific exploration of cannabinoids and their medical potential. CBD opened the door, and now we’re walking through it with a toolkit of cutting-edge science. We are expanding our R&D to study lesser-known cannabinoids like CBG (cannabigerol) and CBN (cannabinol), which are also derived from hemp but have unique properties. For instance, recent research from Yale University highlighted CBG’s strong potential for pain relief without opioid risks, and ongoing studies suggest CBN may aid sleep. We believe these compounds, especially in synergy (the “entourage effect”), could address health issues that CBD alone hasn’t fully solved. To that end, Inspirational Technologies is initiating clinical collaborations to formally test cannabinoid-based therapies for specific conditions. We’re in discussions with medical centers to launch trials on a CBD-CBG blend for chronic neuropathic pain and on a cannabinoid regimen for anxiety and PTSD. The goal is to move beyond wellness products into the realm of evidence-backed therapeutics – bridging the gap between supplement and medicine. It’s an ambitious step, but it’s aligned with our founding mission of merging nature with advanced science. The scientific promise is truly compelling: studies show cannabinoids might offer safer alternatives to opioids for pain, relieve anxiety without harsh side effects, and even help in neurodegenerative diseases like Alzheimer’s. In 2018, the U.S. FDA approved its first CBD-based prescription drug for severe childhood epilepsy, validating that cannabinoids can meet the highest standards of medicine. We foresee a future where cannabinoid therapies are a trusted part of mainstream healthcare, and we want to be at the forefront of that movement. Our new direction prioritizes rigorous research, so doctors and patients can have confidence in the hemp-derived treatments we develop. [Cannabinoi…ain relief], [Cannabinoi…ain relief][Cannabinoi…ain relief][CBD shown…e with THC], [CBD shown…e with THC][Frontiers…: from …][What Does…usinesses?]
2. Emerging Applications in Disease Relief: We are also broadening the applications of our products to target more specific needs. Over the years, customers have shared incredible stories of finding relief with our creams and tinctures – from an athlete’s persistent knee pain easing to an anxious traveler finally enjoying a calm flight. These experiences inspire us to tailor solutions for some of the most prevalent and pressing health challenges. Chronic pain, for example, affects millions and often leads to dependence on painkillers. With cannabinoids showing effectiveness in reducing inflammation and pain signaling, we are formulating targeted pain-relief applications, such as an advanced arthritis cream and oral supplements for inflammatory conditions. Mental health is another focus: anxiety and sleep issues are on the rise, and many are seeking natural relief. We’re exploring blends of CBD with terpenes and botanicals known for calming effects, to support those struggling with stress or insomnia. Early next year, we plan to release a CBD+CBN nightly tincture aimed at improving sleep quality naturally. On the more advanced end, we’re keeping an eye on research that suggests cannabinoids could play a role in serious conditions like cancer. A recent comprehensive study even found evidence that cannabis compounds might help fight certain cancer cells and improve patients’ quality of life. While we remain grounded in science (and such uses will require extensive validation), it underscores a key point: the therapeutic horizon of hemp is still expanding. Our new product roadmap is designed to adapt as new discoveries emerge. If a study finds that a CBD-THC combination (with minimal THC) works best for a given condition, we have the agility and knowledge to formulate accordingly – always within legal bounds. In short, we’re widening our scope from general wellness to targeted solutions for disease relief, driven by what science and our users tell us. [Cannabinoi…ain relief][New Study…naging …], [New Study…naging …]
3. Market Expansion and Leadership: As we venture into these new arenas, Inspirational Technologies is committed to growing sustainably and responsibly. The hemp and CBD industry is maturing – consolidation is happening, regulations are catching up, and consumers are becoming more discerning. We see this as a positive evolution and aim to be a leader in the next phase of the market’s development. Part of our new direction involves stepping up our role in industry advocacy. We are actively engaging with policymakers and regulatory bodies to help shape commonsense regulations for hemp products. Our stance is that quality and safety standards are needed to weed out bad actors selling mislabeled or impure products. We’re advocating for measures like third-party lab testing requirements, proper labeling, and research-based dosage guidelines. We’re also preparing for the potential regulatory changes ahead. The FDA in the U.S. has hinted at developing a new framework for CBD in dietary supplements or foods, and bipartisan bills in Congress aim to clarify CBD’s legal status further. We welcome clearer regulations, and our team is proactively ensuring that whenever new rules come, we will not just comply but excel under them.
On the market front, we are exploring geographic expansion. Hemp’s acceptance is global now – countries across Europe, Latin America, and Asia-Pacific are embracing hemp CBD as laws evolve. Through the next couple of years, we plan to enter select international markets. We’re already laying groundwork in Canada and the EU, navigating their approval processes to offer our products abroad. Additionally, we’ll continue forging strategic partnerships. Just as our alliance with hempSMART accelerated U.S. growth, we’re eyeing partnerships in new regions (for example, a potential joint venture in Europe with a local wellness company) to bring our expertise to new audiences. At home, as the competitive landscape grows, we differentiate by staying true to science and innovation.
Product innovation remains key: our R&D pipeline includes not only new formulations but also new delivery technologies (imagine a transdermal patch for steady cannabinoid release, or a smart dispenser that gives personalized doses based on an app). Advanced technology – from bioinformatics to AI-driven data analysis – will increasingly inform how we design and validate our products, fulfilling the “advanced science” part of our mission with even greater precision.
Finally, as we look beyond 2025, Inspirational Technologies’ core values stay constant. The resilience, curiosity, and purpose that got us through the past decade will guide us in the next. We envision a future where a person with chronic pain might use a cannabinoid therapy we helped develop instead of habit-forming opioids; where someone with anxiety can find calm through a natural remedy backed by clinical evidence; and where hemp-based innovations contribute to a healthier, more sustainable world. The journey from a startup in 2013 to here has taught us that nature’s solutions and human ingenuity are an unstoppable combination. Our new direction doubles down on that truth. [Cannabinoi…ain relief]
Milestones and Future Goals at a Glance
To recap our journey and where we’re headed, here’s a summary of Inspirational Technologies’ major milestones over the past decade and our key goals for the future:
Year/Period
Major Milestones
Future Goals
2013
Founding: Steven Smith establishes Inspirational Technologies in Florida with a mission to merge natural wellness and advanced science. Begins research into hemp and medicinal herbs.
Global Health Impact: Leverage hemp compounds to improve lives worldwide, bridging nutraceuticals and pharmaceuticals.
2014
First Investment & Website Launch: Secures initial private funding. Launches InspirationalTech.org as an educational hub to share research and combat misconceptions about hemp.
Educational Leadership: Continue to educate consumers and health professionals about cannabinoids, setting industry standards for transparency.
2015
Research Foundations: Early lab studies on hemp compounds suggest potential benefits (anxiety reduction, anti-inflammatory effects). Establishes academic collaborations to validate findings.
Research & Development: Invest in clinical trials and R&D for new cannabinoid therapies (e.g., pain, anxiety, neuroprotection), turning promising research into approved treatments.
2016–2017
Focus on CBD & Product Prototypes: Pivots to focus on hemp-derived CBD as interest grows. Develops first CBD product prototypes (topical cream and tincture) blending botanical science with tech.
Product Innovation: Develop next-gen products (e.g., multi-cannabinoid formulas, improved delivery systems like patches or nano-emulsions) for more effective relief.
2018
Regulatory Breakthrough: U.S. Farm Bill 2018 legalizes hemp federally [What Does…usinesses?], [What Does…usinesses?], removing major legal barriers. Inspirational Tech poised to enter the national market with tested products.
Quality & Compliance: Lead in product quality, exceeding regulatory requirements. Work with regulators (FDA, etc.) to establish clear guidelines that ensure consumer safety and trust.
2019
Product Launch & hempSMART Partnership: Launches first retail products nationwide. Partners with hempSMART to expand reach and co-develop offerings, boosting brand visibility and distribution.
Strategic Partnerships: Build new alliances (with wellness companies, research institutes, healthcare providers) to expand globally and integrate hemp solutions into mainstream wellness and medicine.
2020–2021
Rapid Growth: Surges in customer adoption amid rising CBD popularity. Expands team and facilities; recognised in industry for science-driven approach. U.S. CBD use jumps (33% of Americans by 2020) despite lingering stigma.
Market Expansion: Enter new markets in Europe, Canada, and Asia as global hemp legalization progresses. Continue to adapt to market trends and consumer needs with agility.
2022
Industry Leadership: Establishes itself as a leading hemp innovation company. By 2022, U.S. CBD sales reach $1.9B [CBD Statis…bes Health] and 60% of adults have tried CBD [CBD Statis…bes Health] – a testament to growing acceptance that Inspirational Tech helped foster.
Industry Leadership & Advocacy: Influence the hemp industry’s evolution by advocating for sustainable practices, environmental responsibility in cultivation, and social responsibility in marketing (ensuring products are used appropriately for wellness).
2023
New Initiatives: Kicks off new R&D projects on cannabinoids like CBG/CBN for pain and sleep. Prepares for clinical collaborations to formally study cannabinoid therapies. Company culture shifts toward biotech startup mindset (hiring medical liaisons, data scientists).
Therapeutic Breakthroughs: Aim to achieve at least one FDA-approved cannabinoid therapy in the next 5–7 years, bringing a natural yet scientifically-vetted medicine to patients (e.g., a prescription CBD/CBG pain reliever).
2024
Preparation for New Direction: Aligns strategy with market trends and scientific advances. Strengthens compliance team for anticipated regulations. Engages with lawmakers on CBD policy. Concepts for personalized cannabinoid wellness programs (leveraging AI) in development.
Personalized Wellness: Utilize technology (AI and data analytics) to tailor cannabinoid-based solutions to individual needs, ushering in an era of personalized, plant-based medicine.
2025 & Beyond
Announcing New Direction: Unveils a forward-looking strategy focusing on advanced research, broader health applications, and global expansion. Poised to integrate hemp-based innovation into healthcare on a larger scale, staying true to the vision of holistic wellness powered by science.
Vision 2030: By 2030, become a global pioneer in cannabinoid science, with a portfolio spanning consumer health products, licensed medical treatments, and technological platforms – all while maintaining the trust and holistic principles that have defined Inspirational Technologies since 2013.
Conclusion: by Steven M. Smith
“As we step into this new chapter, Inspirational Technologies remains guided by the same principle that sparked our founding: the belief that nature and science together can improve lives. Our journey from 2013 to 2025 has been one of learning, innovating, and breaking barriers. We transformed challenges into opportunities – whether overcoming legal hurdles or shifting public perception – and in doing so, we’ve helped pave the way for hemp-based wellness worldwide. The future of hemp and cannabinoids is bright. From emerging scientific breakthroughs to evolving market dynamics, all signs point to an era where these natural compounds take a more central role in health and wellbeing.
With our rich history and renewed focus, we’re ready to lead in that era. The coming years will see Inspirational Technologies diving deeper into research, launching exciting new solutions, and reaching people in ways we once only imagined. We extend our heartfelt thanks to our supporters, partners, and customers who have believed in our mission. Together, we are forging a new path for natural wellness – one that honors ancient wisdom, embraces modern innovation, and inspires a healthier future for all.”
Stay tuned for more updates as we embark on this journey ahead. The best is yet to come.
All Rights Reserved – Inspirational Technologies 2025We hope this information has been helpful and informative. Don’t hesitate to reach out with any further questions. 😊Inspirational Technologies – IT is TimeAt Inspirational Technologies, we take pride in being pioneers and innovators in the constantly evolving world of technology.Life often presents personal challenges that shape our relationships with family and peers.Steven M. Smith, CEO of InspirationalTech.org since 2013.Thank you for considering Inspirational Technologies.Visit InspirationalTech.org to explore your health, wellness, beauty, and inspirational goals.Discover more about Cannabis, CBD, and YOU.Steven M Smith InspirationalTech.org CEO since 2013.Inspirational Technologies (2025)
1st Hemp USA News is a resource of Inspirational Technologies (2021)
Logo by Steven M Smith Created 3/1/2014
*This site operates with minimal compensation for product sales. Humanitarian values are prioritized over monetary gains. Income supports research, development, discovery, and healing.
Inspirational Technologies is committed to your health, wellness, beauty, and enrichment.
Reporting on today’s botanical and skincare product benefits.
What is in store for Hemp Derived Products in 2024. History may repeat itself.
CBD companies are tasked with seizing this opportunity while navigating the significant hurdles. As a founder and owner, here is my take on the crucial developing issues in my industry, along with predictions about what will happen.
CBD sales in the U.S. hit $4.6 billion in 2020, a massive number just two years after hemp-derived cannabinoids were federally legalized. This growth is only expected to accelerate, with two notable forecasts projecting a U.S. market of $15 billion to more than $20 billion by 2025 and 2024, respectively.
CBD companies currently offer a pretty wide range of products. Nevertheless, this diversity will increase as more companies introduce products that hyper-concentrate on each of the over 100 minor cannabinoids found in the hemp plant. Formulations focusing on cannabinol (CBN), cannabigerol (CBG) and other compounds and mixes will be developed for specific use cases.
2. Regulatory challenges remain, and it will take Congress to clarify things.
Despite being federally legal, we’ve observed that CBD companies still have problems obtaining capital and standard services from banks and other financial services institutions. And the ability to market CBD as a safe and effective substance is limited by how the FDA classifies it.
Ultimately, the U.S. Congress has the authority to address these issues, and there is current legislation aiming to do just that, such as the Safe Banking Act of 2021, the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 and the Hemp Access and Consumer Safety Act. Crucially, those last two pieces of legislation would pave the way for the FDA to authorize marketing CBD as a dietary supplement. This development will open up many forbidden or restricted marketing and distribution channels, leading to greater sales and brand exposure.
3. Big-box retail access will spur sales while stabilizing and improving supply chains.
Once companies can market CBD as a dietary supplement, it’s my opinion that it will hit the mainstream of brick-and-mortar retail. In particular, big-box chains will offer a range of topicals and ingestibles in various product categories and applications.
This new distribution could vastly grow the market while benefiting various supply chain components, including hemp farmers and labs that conduct the extraction, distillation, crystallization and isolation of CBD from plants. A particular benefit will be incentivizing more quality labs to get in the CBD game, as many facilities now hesitate to stray from their core competencies. The price of raw materials will also drastically increase as retail demand grows.
4. More big names will get into the game through acquisitions.
Huge companies have been hesitant to embrace CBD as its initially “Wild West” market goes through growing pains. But once the regulatory landscape clears and stabilizes, I believe many corporate giants will look to diversify their product lines with CBD and add brand-new products that open avenues of growth. Companies like Procter & Gamble, Johnson & Johnson, Coca-Cola, Unilever and more may get into the game, and they’ll do it through acquisitions of existing CBD market leaders.
Affecting industries as diverse as cosmetics, food and beverage and pharmaceuticals, the exploding CBD (cannabidiol) market has generated considerable headlines, providing fodder to umpteenth analysis and forecasts. The latest one, by leading cannabis researchers BDS Analytics and Arcview Market Research, projects that the collective market for CBD sales in the U.S. will surpass $20 billion by 2024.
5. Education, quality assurance and safety will skyrocket.
An all-time high in public education about cannabinoids will accompany the mainstreaming of CBD. Through this, consumers will be able to feel more confident and safer while purchasing products that are smartly regulated.
Many CBD companies, which now mainly self-regulate, will be forced to improve their quality assurance and compliance efforts to survive. And the providers who already sell high-caliber products will finally reap the rewards of their investments in R&D and production that have necessarily reduced ROI.
The future of CBD is bright, but it still hinges on crucial developments.
In some ways, the CBD industry is an unstoppable juggernaut. It’s already a multi-billion-dollar sector that will only get bigger, as millions of consumers have made their preferences clear. But CBD companies still have to navigate many unique hurdles, from obtaining capital to using standard payment processing to being able to market on regular channels.
The crucial developments that will remove these barriers are the FDA classifying CBD as a dietary supplement, the industry’s unrestricted access to financial services and an intelligent regulatory framework that increases product quality and safety across the board.
As the owner of a CBD company, I am in wait-and-see mode like many of my colleagues. We simply steer through these challenges to grow our companies. But I believe that lawmakers will solidify the status of CBD soon, removing barriers to innovation, safety and, ultimately, the normalization of the industry. When that happens, even more growth — exponential growth — is on the horizon.
According to a Forbes article, the CBD industry is in a unique position as a substance that was federally illegal before the passage of the 2018 Farm Bill, hemp-derived cannabinoids with no more than 0.3% THC still face a regulatory grey area. This ambiguity creates a host of novel challenges in financing, marketing and producing products. But simultaneously, the industry and market are growing incredibly fast. CBD sales in the U.S. hit $4.6 billion in 2020, a massive number just two years after hemp-derived cannabinoids were federally legalized. This growth is only expected to accelerate, with two notable forecasts projecting a U.S. market of $15 billion to more than $20 billion by 2025 and 2024, respectively. CBD companies currently offer a pretty wide range of products. Nevertheless, this diversity will increase as more companies introduce products that hyper-concentrate on each of the over 100 minor cannabinoids found in the hemp plant. Formulations focusing on cannabinol (CBN), cannabigerol (CBG) and other compounds and mixes will be developed for specific use cases1.
We are often faced with our own personal conflicts which directly influence our interactions with our peers and family.
When Inspirational Technologies is an endorsement of the “Cannabis” approach to the medical condition, we say, let’s let the look at the data and the people who say that they benefit for cannabis alternatives.
Beginning in Late November 2023 Inspirational Technologies will promote the long-awaited series, “In the Weeds with Steve “. An Inspirational Technologies production under their own “Background Noise Productions Studios.
1st Hemp USA News is a resource of Inspirational Technologies (2021-2023)Inspirational Technologies (2023) AllRightsReservedYour ONE STOP BLOG FOR INFORMATION, EDUCATION, & INSPIRATION OF ESSENTIAL INNOVATION & RENOVATION of You-THANK YOU FOR YOUR INTEREST*This site receives virtually no compensation for sales of some or all mentioned products. We however place humanitarian value over monetary interests. Our monetary income goes back into research, development, discovery and healing.Inspirational Technologies – is Committed to Your Health Wellness Beauty and EnrichmentReporting on Today’s Internal Botanical and Skin Product Benefits
4 Hemp Club was Inspired by Steven Smith’s vision to “Have an older generation 4H Club, where an older community of adults could carry on what the younger 4H Club envisioned.
Our 4H Platform Uses HEMP as an Agricultural Focal Point, deserving of research, development and with the
4 Hemp key points being Health Hope and Happiness, thru Hemp“.
Cannabis CBD and Me Inspirational Technologies Inspirational Technologies (2014) @Inspire123tech Background Noise Studios Logos bySteven M Smith
We at Inspirational Technologies want to be a broadcaster of current news, trends and headlines in cultural cannabis events. 7/10 presents a representative opportunity to share a uncontrolled, widely taken, faulty informed public with our take on the industry.
As the popularity of concentrates continues to rise within the cannabis community, 7/10 presents a unique opportunity for more dispensaries to showcase their cannabis products, attract new customers, and drive significant sales.
In this blog, we will delve into the strategies and insights derived from analyzing the statistics from previous years’ April 20th and July 10th sales events.
By understanding the cannabis campaign statistics, sales trends, and consumer preferences, we aim to equip cannabis dispensaries with the knowledge and tactics needed to succeed on this special day.
The date itself, “710,” holds symbolic significance, representing the inverted spelling of “OIL” and paying homage to concentrates like oils, extracts, and dabs.
Analyzing the top-selling categories on both 4/20 and 7/10 provides crucial insights into customer preferences. Flower, vapes, and pre-rolls consistently ranked among the top weed categories, indicating their popularity and demand during these sales events. However, there were some variations between the two dates, with edibles being more favored on 4/20 and concentrates gaining prominence on 7/10.
Cannabis Sales Statistics: 4/20 and 7/10
By examining the combined statistics from last year’s 7/10 and 4/20 earlier this year, we can uncover actionable ideas for dispensaries to maximize cannabis sales and success on the upcoming 7/10. Let’s explore the key insights:
Overall Sales Growth: Both 4/20 and 7/10 experienced significant sales growth compared to the previous year, indicating a thriving market and increasing customer demand. Cannabis dispensaries should anticipate a similar upward trend for 7/10 this year and prepare their inventory, staffing, and marketing efforts accordingly to capitalize on the heightened sales potential.
Increasing Total Visits: The number of total visits on both 4/20 and 7/10 demonstrated considerable growth, reflecting a higher influx of customers during these sales events. Dispensaries should focus on optimizing their store layout, enhancing customer experience, and ensuring adequate staffing to accommodate the anticipated increase in foot traffic on 7/10. Implementing measures to reduce wait times and provide personalized assistance can help dispensaries make the most of this heightened customer engagement.
As we approach this year’s 7/10, armed with the insights gained from analyzing the campaign and sales statistics from previous years, dispensaries have the opportunity to develop a well-rounded game plan to maximize their success.
To ensure a successful 7/10, dispensaries should focus on the following strategies:
Tailor Marketing Campaigns: Build upon the success of previous campaigns by leveraging data-driven insights. Craft targeted marketing messages to engage customers and drive sales. Emphasize promotions, discounts, and special deals on popular categories like concentrates, vapes, and pre-rolls. Highlight the products that resonate most with customers during this event.
Optimize Store Operations: Anticipate increased foot traffic and plan for a seamless customer experience. Implement efficient store layouts, manage staffing levels effectively, and consider utilizing technology solutions to streamline operations, reduce wait times, and enhance customer satisfaction.
Curate Product Assortments: Stock up on the products that have historically performed well on 7/10, such as concentrates, vapes, and pre-rolls. Offer a diverse selection of strains, flavors, and varieties to cater to different customer preferences.
Enhance Customer Engagement: Create an inviting and personalized shopping experience. Train staff to provide knowledgeable assistance and recommendations to customers. Consider implementing exclusive perks for 7/10 customers to encourage repeat visits and build customer loyalty.
Leverage Online Presence: Capitalize on the digital space to promote 7/10 sales and deals. Optimize your website, social media platforms, and email/text marketing to generate buzz and reach a wider audience. Consider pre-order options or online-exclusive promotions to cater to customer preferences and convenience.
By implementing these strategies based on the insights gathered from previous 4/20 and 7/10 holidays, cannabis dispensaries can position themselves for success on this highly anticipated sales day. It’s crucial to be proactive in understanding customer behaviors, adapting to market trends, and creating an exceptional experience that exceeds customer expectations. With careful planning and execution, cannabis dispensaries can leverage the 7/10 opportunity to drive sales, cultivate customer loyalty, and establish their brand as a leader in the cannabis industry.
We, at Inspirational Technologies are at the forefront of Inspirational and Frontrunners on the frontier of current technology.
We are often faced with our own personal conflicts which directly influence our interactions with our peers and family.
When Inspirational Technologies is an endorsement of the “Cannabis” approach to the medical condition, we say, let’s let the look at the data and the people who say that they benefit for cannabis alternatives.
1st Hemp USA News is a resource of Inspirational Technologies (2021-2023)Inspirational Technologies (2023) AllRightsReservedYour ONE STOP BLOG FOR INFORMATION, EDUCATION, & INSPIRATION OF ESSENTIAL INNOVATION & RENOVATION of You-THANK YOU FOR YOUR INTEREST*This site receives virtually no compensation for sales of some or all mentioned products. We however place humanitarian value over monetary interests. Our monetary income goes back into research, development, discovery and healing.Inspirational Technologies – is Committed to Your Health Wellness Beauty and EnrichmentReporting on Today’s Internal Botanical and Skin Product Benefits
4 Hemp Club was Inspired by Steven Smith’s vision to “Have an older generation 4H Club, where an older community of adults could carry on what the younger 4H Club envisioned.
Our 4H Platform Uses HEMP as an Agricultural Focal Point, deserving of research, development and with the
4 Hemp key points being Health Hope and Happiness, thru Hemp“.
Cannabis CBD and Me Inspirational Technologies Inspirational Technologies (2014) @Inspire123tech Background Noise Studios Logos bySteven M Smith
Hemp Is Now A Viable Agriculture Phenomenon Cannabis and the Endocannabinoid System; The Wonders of CBDs 
CBD Molecule The following is a reprint with updated references. Cannabinoids are the chemical compounds made by the cannabis plant that unlock its many healing secrets. There are over 100 known cannabinoids and these chemicals imitate the endocannabinoids naturally produced in the human body. The shiny little crystals you see on cannabis buds are called trichomes where cannabinoids are stored. Human bodies (and many animals) have endocannabinoid systems (ECS), meaning that cannabinoids are naturally made so they can bind to endocannabinoid receptors creating changes in our physiology. To understand the master gland and immune system of the human body it is crucial to have a basic understanding of the endogenous cannabinoid system, otherwise known as the endocannabinoid system (ECS). The endocannabinoid system is essential to human health because it maintains homeostasis in the body. Research into the endocannabinoid system has increased in recent years as scientists begin to reveal how complex and important this system is to our bodies. The legal cannabis movement started in San Francisco in the early 1990’s when it was discovered that cannabis treated many symptoms that AIDS patients suffered from, including pain. It was medical marijuana laws that changed the legal status of cannabis nationwide, opening the doors for research and an adult-use market and creating a path towards full legalization. Cannabis patients across the country have used the plant to treat a growing number of medical conditions. In Colorado alone, there are nine different qualifying conditions for a medical card: cancer, glaucoma, HIV or AIDS, cachexia (wasting syndrome), persistent muscle spasms, seizures, severe nausea, severe pain, and Post Traumatic Stress Disorder (PTSD).
Imagine a sweater softer than any fabric you’ve ever felt before, and more durable than cotton. Imagine a car built with something lighter than steel that could stand 10 times the impact without denting. 
Background Noise Studios Logos by Steven M Smith
HempSMART – a California-based company known for its science-driven CBD formulations – shared a similar ethos with us. By partnering, we aimed to combine our strengths: Inspirational Technologies’ research and product innovation, with hempSMART’s established marketing channels and customer base. Together, we celebrated on product development and education. For example, we co-hosted webinars featuring experts like Paula Vetter (hempSMART’s medical advisor) to inform consumers about CBD’s benefits. This partnership expanded our reach across the U.S. and even into international markets where hempSMART had a presence. It was a win-win: hempSMART gained new formulations and R&D support, while we gained a ready distribution network and a boost in brand visibility. Collaboration has always been in our DNA, and this was a powerful example of how working with like-minded innovators could amplify our impact.
Steven M Smith InspirationalTech.org CEO since 2013.Inspirational Technologies (2025)
You must be logged in to post a comment.